Review of Loteprednol Etabonate 0.5%/Tobramycin 0.3% in the Treatment of Blepharokeratoconjunctivitis
Crossref DOI link: https://doi.org/10.1007/s40123-021-00401-x
Published Online: 2021-10-27
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mah, Francis S. http://orcid.org/0000-0001-9575-4590
Karpecki, Paul M.
Funding for this research was provided by:
Bausch + Lomb
Text and Data Mining valid from 2021-10-27
Version of Record valid from 2021-10-27
Article History
Received: 20 August 2021
Accepted: 23 September 2021
First Online: 27 October 2021